Klaria Pharma issues up to 61,494,038 warrants in rights offering
Bitget2026/10/13 16:12- Klaria Pharma registered a prospectus for a rights issue that includes the issuance of up to 61,494,038 warrants series TO1 issued free of charge.
- The warrants will be issued as part of units in a rights issue of up to 61,494,038 units, each comprising four new shares and one warrant.
- Each warrant series TO1 can be exercised to subscribe for one new share at SEK 0.60 during set exercise windows from Nov. 22-26, 2027 through Oct. 17-31, 2029.
- If fully exercised, the warrants could raise about SEK 36.9 million before issue costs.
- Klaria plans to seek admission to trading of the warrants on Nasdaq First North Growth Market.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
U.S. stock futures fluctuate by $650 billions due to news related to Jensen Huang
Nikkei Average Index gains expand to 2.78%
Surprise! Japan intervened in the forex market three times this summer, selling a record 154 trillion yen in three days
Japan has confirmed that it intervened in the foreign exchange market three times this summer, buying yen to support the exchange rate, corroborating earlier market reports. This included the first joint intervention with the United States to support the yen in nearly thirty years.
UBS CEO warns: A Democratic sweep could slow down AI capacity building, valuation concerns are "very important"
UBS CEO Ermotti stated that the U.S. midterm elections may slow down AI capacity building and that the valuations are questionable; he also warned of persistent inflation and the risk of contagion in the European bond market.
Crypto prices
More
